Atlas Trials

Assessment of the Efficacy of the Neoadjuvant Combination: "Chemotherapy-Targeted Therapy" in Breast Cancer.

Clinical trial NCT00933517 · COMPLETED

Trial details

NCT number
NCT00933517
Sponsor
Centre Jean Perrin
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pathological Response Rate
Start date
2009-09-01
Primary completion
2011-10-01
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.